全球誘導性多功能幹細胞市場（按細胞來源、應用、最終用戶和地區分類）

Global Induced Pluripotent Stem Cells Market, By Cell Source, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球誘導性多功能幹細胞市場規模估計為 15.99 億美元，預計到 2032 年將達到 33.831 億美元，2025 年至 2032 年的複合年成長率為 11.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	15.99億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	11.30%	2032年價值預測	33.831億美元

數字。 2025年全球市場佔有率誘導性多功能幹細胞各地區市佔率（%）

誘導性多功能幹細胞(iPSC) 是一種可直接從成人細胞產生的多功能細胞。誘導性多功能幹細胞的發現徹底改變了再生醫學領域，因為它提供了比胚胎幹細胞更符合倫理道德的替代方案。誘導性多功能幹細胞(iPSC) 是一種經過基因重編程成為類似胚胎幹細胞多功能狀態的成體細胞。 iPSC 用於再生醫學研究，以研究疾病機制、藥物發現和毒性篩檢。 iPSC 的再生特性為開發以細胞為基礎的治療方法提供了機會。這些細胞透過引入或過度表達關鍵轉錄因子從分化的成體細胞重新編程，使其在分化潛力和多功能標記的表達方面回歸到類似於胚胎幹細胞的狀態。這項技術對於開發特異性患者和疾病的幹細胞模型以用於藥物發現、毒性篩檢和再生療法具有巨大的前景。

市場動態：

全球誘導性多功能幹細胞市場受到慢性病發病率上升、器官移植數量增加以及生物製藥公司為開發新型幹細胞治療方法而增加的研發 (R&D) 投資的推動。然而，iPS細胞研究和臨床應用的高成本以及細胞重編程和幹細胞分化的技術挑戰正在抑制市場成長。另一方面，幹細胞技術的持續進步，例如標準培養方法的建立、無異種重編程方法的開發以及大規模幹細胞生產的進展，預計將為市場相關人員提供豐厚的成長機會。

本研究的主要特點

本報告對全球誘導性多功能幹細胞市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，列出了全球誘導性多功能幹細胞市場的主要企業。
報告涉及的主要企業包括 Takara Bio、賽默飛世爾科技、FUJIFILM Holdings、Astellas製藥、Fate Therapeutics、Ncardia、ViaCyte、Cellular Dynamics International、Lonza、Blueprint Medicines 等。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
全球誘導性多功能幹細胞市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球誘導性多功能幹細胞市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,599.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 3,383.1 Mn

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternative to embryonic stem cells. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like pluripotent state. iPSCs are used in regenerative medicine research to study mechanisms of disease and for drug discovery and toxicity screening. Regenerative properties of iPSCs provide opportunities for developing cell-based therapies. These cells are reprogrammed from their original differentiated adult cells through the introduction or overexpression of key transcription factors that enable them to regress to a state that resembles embryonic stem cells in terms of differentiation potential and expression of pluripotency markers. This technology holds tremendous promise for developing patient and disease specific stem cell models for drug discovery, toxicity screening, and regenerative therapies.

Market Dynamics:

Global induced pluripotent stem cells market is driven by rising prevalence of chronic diseases, increasing adoption of organ transplantation and growing research and development (R&D) investments by biopharmaceutical companies for developing novel stem cell-based therapies. However, high costs that are associated with iPSC research and clinical applications, technical challenges in cell reprogramming and stem cell differentiation are restraining wider market growth. Meanwhile, ongoing advancements in stem cell technologies including establishment of standard culture practices, development of xeno-free reprogramming methods and progress in large-scale stem cell production are expected to offer lucrative growth opportunities for market players.

Key features of the study:

This report provides an in-depth analysis of the global induced pluripotent stem cells market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global induced pluripotent stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines, and Other Prominent Players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global induced pluripotent stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global induced pluripotent stem cells market.

Detailed Segmentation:

By Cell Source:
- Skin derived iPSCs
- Blood derived iPSCs
- Urine Derived iPSCs
- Hepatocytes derived iPSCs
- Lung fibroblast derived iPSCs
- Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
By Application:
- Culture & Maintenance
- Differentiation
- Genetic Manipulation & Engineering
- Characterization & Validation
- Banking & Storage
- Others (Reprogramming kits, Analysis software etc.)
By End User:
- Hospitals
- Diagnostics Centers
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others (Academic & Research Institutes etc.)
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Takara Bio Inc.
- Thermo Fisher Scientific
- Fujifilm Holdings Corporation
- Astellas Pharma
- Fate Therapeutics
- Ncardia
- ViaCyte
- Cellular Dynamics International
- Lonza
- Blueprint Medicines
- Other Prominent Players

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Induced Pluripotent Stem Cells Market Snippet, By Cell Source
- Global Induced Pluripotent Stem Cells Market Snippet, By Application
- Global Induced Pluripotent Stem Cells Market Snippet, By End User
- Global Induced Pluripotent Stem Cells Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Induced Pluripotent Stem Cells Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Induced Pluripotent Stem Cells Market, By Cell Source, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Skin derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Blood derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Urine Derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hepatocytes derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Lung fibroblast derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Induced Pluripotent Stem Cells Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Culture & Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Differentiation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Genetic Manipulation & Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Characterization & Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Banking & Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Reprogramming kits, Analysis software etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Induced Pluripotent Stem Cells Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Academic & Research Institutes etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Induced Pluripotent Stem Cells Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Takara Bio Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Thermo Fisher Scientific
- Fujifilm Holdings Corporation
- Astellas Pharma
- Fate Therapeutics
- Ncardia
- ViaCyte
- Cellular Dynamics International
- Lonza
- Blueprint Medicines
- Other Prominent Players
Analyst Views